Cutter GR - Search Results

1

Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.

Schneider LS, Kennedy RE, Cutter GR; Alzheimer’s Disease Neuroimaging Initiative. Schneider LS, et al. Among authors: cutter gr. Alzheimers Dement. 2010 Sep;6(5):367-77. doi: 10.1016/j.jalz.2010.07.004. Alzheimers Dement. 2010. PMID: 20813339 Free PMC article.

2

Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?

Kennedy RE, Cutter GR, Wang G, Schneider LS. Kennedy RE, et al. Among authors: cutter gr. Alzheimers Dement (N Y). 2015 Jun;1(1):46-52. doi: 10.1016/j.trci.2015.03.001. Alzheimers Dement (N Y). 2015. PMID: 27695707 Free PMC article.

3

Challenging Assumptions About African American Participation in Alzheimer Disease Trials.

Kennedy RE, Cutter GR, Wang G, Schneider LS. Kennedy RE, et al. Among authors: cutter gr. Am J Geriatr Psychiatry. 2017 Oct;25(10):1150-1159. doi: 10.1016/j.jagp.2017.04.013. Epub 2017 Apr 25. Am J Geriatr Psychiatry. 2017. PMID: 28554539 Free PMC article.

4

Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment.

Wang G, Kennedy RE, Cutter GR, Schneider LS. Wang G, et al. Among authors: cutter gr. Alzheimers Dement (N Y). 2015 Apr 14;1(1):63-71. doi: 10.1016/j.trci.2015.03.002. eCollection 2015 Jun. Alzheimers Dement (N Y). 2015. PMID: 29854926 Free PMC article.

5

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.

Kennedy RE, Cutter GR, Fowler ME, Schneider LS. Kennedy RE, et al. Among authors: cutter gr. JAMA Netw Open. 2018 Nov 2;1(7):e184080. doi: 10.1001/jamanetworkopen.2018.4080. JAMA Netw Open. 2018. PMID: 30646339 Free PMC article.

6

Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative.

Fowler ME, Triebel KL, Cutter GR, Schneider LS, Kennedy RE; Alzheimer’s Disease Neuroimaging Initiative. Fowler ME, et al. Among authors: cutter gr. J Alzheimers Dis. 2020;76(2):691-701. doi: 10.3233/JAD-200108. J Alzheimers Dis. 2020. PMID: 32538844 Free PMC article.

7

Biomarker positive and negative subjects in the ADNI cohort: clinical characterization.

Kennedy RE, Schneider LS, Cutter GR; Alzheimer's Disease Neuroimaging Initiative. Kennedy RE, et al. Among authors: cutter gr. Curr Alzheimer Res. 2012 Dec;9(10):1135-41. doi: 10.2174/156720512804142976. Curr Alzheimer Res. 2012. PMID: 22963265

8

Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.

Kennedy RE, Cutter GR, Schneider LS. Kennedy RE, et al. Among authors: cutter gr. Alzheimers Dement. 2014 May;10(3):349-59. doi: 10.1016/j.jalz.2013.03.003. Epub 2013 May 25. Alzheimers Dement. 2014. PMID: 23712001 Free PMC article.

9

Differences in Alzheimer disease clinical trial outcomes based on age of the participants.

Schneider LS, Kennedy RE, Wang G, Cutter GR. Schneider LS, et al. Among authors: cutter gr. Neurology. 2015 Mar 17;84(11):1121-7. doi: 10.1212/WNL.0000000000001376. Epub 2015 Feb 13. Neurology. 2015. PMID: 25681452 Free PMC article.

10

Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.

Kennedy RE, Cutter GR, Wang G, Schneider LS. Kennedy RE, et al. Among authors: cutter gr. J Alzheimers Dis. 2016;50(4):1205-15. doi: 10.3233/JAD-150847. J Alzheimers Dis. 2016. PMID: 26836180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

720 results

Search Page

Filters